• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biosaf Health . Genomic characteristics of SARS-CoV-2 in Beijing, 2021

tetano

Editor, Senior Moderator
Biosaf Health


. 2022 May 12.
doi: 10.1016/j.bsheal.2022.04.006. Online ahead of print.
Genomic characteristics of SARS-CoV-2 in Beijing, 2021


Zhaomin Feng[SUP] 1 [/SUP], Shujuan Cui[SUP] 1 [/SUP], Bing Lyu[SUP] 1 [/SUP], Zhichao Liang[SUP] 1 [/SUP], Fu Li[SUP] 1 [/SUP], Lingyu Shen[SUP] 1 [/SUP], Hui Xu[SUP] 1 [/SUP], Peng Yang[SUP] 1 [/SUP], Quanyi Wang[SUP] 1 [/SUP], Daitao Zhang[SUP] 1 [/SUP], Yang Pan[SUP] 1 [/SUP]



Affiliations

Abstract

At present, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, which has emerged multiple variants and brought a global threat to public health. To analyze the genomic characteristics and variations of SARS-CoV-2 imported in Beijing, we collected the respiratory tract specimens of 112 cases of coronavirus disease 2019 (COVID-19) from January to September 2021 in Beijing, including 40 local cases and 72 imported cases. The whole-genome sequences of the viruses were sequenced by the next-generation sequencing method. Variant markers and phylogenic features of SARS-CoV-2 were analyzed. Our results showed that in all 112 sequences, the mutations were concentrated in spike protein. D614G was found in all sequences, and mutations including L452R, T478K, P681R/H, and D950N in some cases. Furthermore, 112 sequences belonged to 23 lineages by phylogenetic analysis. B.1.1.7 (Alpha) and B.1.617.2 (Delta) lineages were dominant. Our study drew a variation image of SARS-CoV-2 and could help evaluate the potential risk of COVID-19 for pandemic preparedness and response.

Keywords: Genome; Phylogenetic analysis; Severe acute respiratory syndrome coronavirus 2; Variation.
 
Back
Top Bottom